{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T05:25:20Z","timestamp":1740029120265,"version":"3.37.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1124\/jpet.111.185686","type":"journal-article","created":{"date-parts":[[2011,9,9]],"date-time":"2011-09-09T13:21:29Z","timestamp":1315574489000},"page":"896-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Modeling Diabetes Disease Progression and Salsalate Intervention in Goto-Kakizaki Rats"],"prefix":"10.1016","volume":"339","author":[{"given":"Yanguang","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra C.","family":"DuBois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Almon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Jusko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.111.185686_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1677\/JOE-08-0404","article-title":"Gene expression analysis of hepatic roles in cause and development of diabetes in Goto-Kakizaki rats","volume":"200","author":"Almon","year":"2009","journal-title":"J Endocrinol"},{"key":"10.1124\/jpet.111.185686_bib2","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0026-0495(97)90075-5","article-title":"Lack of deterioration of insulin action with aging in the GK rat: a contrasted adaptation as compared with nondiabetic rats","volume":"46","author":"Berthelier","year":"1997","journal-title":"Metabolism"},{"key":"10.1124\/jpet.111.185686_bib3","doi-asserted-by":"crossref","first-page":"E807","DOI":"10.1152\/ajpendo.1993.265.5.E807","article-title":"Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver","volume":"265","author":"Bisbis","year":"1993","journal-title":"Am J Physiol Endocrinol Metab"},{"year":"2009","author":"D\u2019Argenio","series-title":"ADAPT V User\u2019s Guide: Pharmacokinetic\/Pharmacodynamic System Analysis Software","key":"10.1124\/jpet.111.185686_bib4"},{"key":"10.1124\/jpet.111.185686_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/187153011794982086","article-title":"The evil axis of obesity, inflammation and type-2 diabetes","volume":"11","author":"Das","year":"2011","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1124\/jpet.111.185686_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF01061691","article-title":"Comparison of four basic models of indirect pharmacodynamic responses","volume":"21","author":"Dayneka","year":"1993","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1124\/jpet.111.185686_bib7","doi-asserted-by":"crossref","first-page":"E1462","DOI":"10.1152\/ajpendo.90444.2008","article-title":"Mathematical models of diabetes progression","volume":"295","author":"De Gaetano","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.111.185686_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10928-006-9008-2","article-title":"A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus","volume":"33","author":"de Winter","year":"2006","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/jpet.111.185686_bib9","first-page":"325","article-title":"Islet inflammation impairs the pancreatic \u03b2-cell in type 2 diabetes","volume":"24","author":"Donath","year":"2009","journal-title":"Physiology (Bethesda)"},{"key":"10.1124\/jpet.111.185686_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/13813450903025879","article-title":"Pancreatic islet inflammation in type 2 diabetes: from \u03b1 and \u03b2 cell compensation to dysfunction","volume":"115","author":"Ehses","year":"2009","journal-title":"Arch Physiol Biochem"},{"key":"10.1124\/jpet.111.185686_bib11","doi-asserted-by":"crossref","first-page":"13998","DOI":"10.1073\/pnas.0810087106","article-title":"IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat","volume":"106","author":"Ehses","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/jpet.111.185686_bib12","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1126\/science.270.5244.2017","article-title":"The effect of sodium salicylate and aspirin on NF-\u03baB","volume":"270","author":"Frantz","year":"1995","journal-title":"Science"},{"key":"10.1124\/jpet.111.185686_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10928-010-9182-0","article-title":"Mechanism-based disease progression modeling of type 2 diabetes in Goto-Kakizaki rats","volume":"38","author":"Gao","year":"2011","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1124\/jpet.111.185686_bib14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.pharmtox.011008.145613","article-title":"Quantitative disease, drug, and trial models","volume":"49","author":"Gobburu","year":"2009","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.111.185686_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial","volume":"152","author":"Goldfine","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.111.185686_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1752-8062.2008.00026.x","article-title":"Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes","volume":"1","author":"Goldfine","year":"2008","journal-title":"Clin Transl Sci"},{"key":"10.1124\/jpet.111.185686_bib17","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/jps.2600691109","article-title":"High-pressure liquid chromatographic determination of salicylsalicylic acid, aspirin, and salicylic acid in human plasma and urine","volume":"69","author":"Harrison","year":"1980","journal-title":"J Pharm Sci"},{"key":"10.1124\/jpet.111.185686_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00125-008-1239-x","article-title":"The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study","volume":"52","author":"Koska","year":"2009","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.111.185686_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006963","article-title":"Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat","volume":"4","author":"Lacraz","year":"2009","journal-title":"PLoS One"},{"key":"10.1124\/jpet.111.185686_bib20","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1124\/jpet.108.144766","article-title":"Mechanism-based modeling of nutritional and leptin influences on growth in normal and type 2 diabetic rats","volume":"328","author":"Landersdorfer","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.111.185686_bib21","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa065213","article-title":"Interleukin-1-receptor antagonist in type 2 diabetes mellitus","volume":"356","author":"Larsen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.111.185686_bib22","first-page":"159","article-title":"Quantification of disease progression","volume":"2","author":"Madden","year":"1980","journal-title":"Prot Ecol"},{"issue":"Suppl 1","key":"10.1124\/jpet.111.185686_bib23","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.numecd.2005.10.017","article-title":"The pancreatic \u03b2-cell in human type 2 diabetes","volume":"16","author":"Marchetti","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1124\/jpet.111.185686_bib24","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1210\/jc.2010-1816","article-title":"Stimulation of human whole-body energy expenditure by salsalate is fueled by higher lipid oxidation under fasting conditions and by higher oxidative glucose disposal under insulin-stimulated conditions","volume":"96","author":"Meex","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/jpet.111.185686_bib25","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s001250050768","article-title":"Impaired development of pancreatic \u03b2-cell mass is a primary event during the progression to diabetes in the GK rat","volume":"40","author":"Movassat","year":"1997","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.111.185686_bib26","doi-asserted-by":"crossref","first-page":"R1117","DOI":"10.1152\/ajpregu.1990.259.6.R1117","article-title":"Model of spontaneous obesity in aging male Wistar rats","volume":"259","author":"Newby","year":"1990","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1124\/jpet.111.185686_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2011.02.016","article-title":"Differential muscle gene expression as a function of disease progression in Goto-Kakizaki diabetic rats","volume":"338","author":"Nie","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/jpet.111.185686_bib28","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4158\/EP10112.RA","article-title":"Preservation of \u03b2-cell function in type 2 diabetes","volume":"16","author":"Nyalakonda","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1124\/jpet.111.185686_bib29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","article-title":"Macrophages, inflammation, and insulin resistance","volume":"72","author":"Olefsky","year":"2010","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/jpet.111.185686_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0026-0495(97)90301-2","article-title":"Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus","volume":"46","author":"O\u2019Rourke","year":"1997","journal-title":"Metabolism"},{"key":"10.1124\/jpet.111.185686_bib31","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00125-008-0999-7","article-title":"Induction of nuclear factor-\u03baB and its downstream genes by TNF-\u03b1 and IL-1\u03b2 has a pro-apoptotic role in pancreatic \u03b2 cells","volume":"51","author":"Ortis","year":"2008","journal-title":"Diabetologia"},{"key":"10.1124\/jpet.111.185686_bib32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mce.2008.06.013","article-title":"The GK rat \u03b2-cell: a prototype for the diseased human \u03b2-cell in type 2 diabetes?","volume":"297","author":"Portha","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1124\/jpet.111.185686_bib33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2337\/diab.40.4.486","article-title":"\u03b2-Cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes","volume":"40","author":"Portha","year":"1991","journal-title":"Diabetes"},{"key":"10.1124\/jpet.111.185686_bib34","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1177\/0091270009349711","article-title":"A model for glucose, insulin, and \u03b2-cell dynamics in subjects with insulin resistance and patients with type 2 diabetes","volume":"50","author":"Ribbing","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.111.185686_bib35","doi-asserted-by":"crossref","first-page":"24929","DOI":"10.1074\/jbc.M402440200","volume":"279","author":"Standaert","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.111.185686_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1006\/jtbi.2000.2150","article-title":"A model of \u03b2-cell mass, insulin, and glucose kinetics: pathways to diabetes","volume":"206","author":"Topp","year":"2000","journal-title":"J Theor Biol"},{"key":"10.1124\/jpet.111.185686_bib37","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.lfs.2004.09.038","article-title":"Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki rats","volume":"76","author":"Ueta","year":"2005","journal-title":"Life Sci"},{"key":"10.1124\/jpet.111.185686_bib38","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1476-5381.1984.tb16464.x","article-title":"Influence of age, sex, pregnancy and protein-calorie malnutrition on the pharmacokinetics of salicylate in rats","volume":"82","author":"Varma","year":"1984","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.111.185686_bib39","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI25102","article-title":"Inflammation, stress, and diabetes","volume":"115","author":"Wellen","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.111.185686_bib40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/421713a","article-title":"Physiology: why does metabolic rate scale with body size?","volume":"421","author":"West","year":"2003","journal-title":"Nature"},{"key":"10.1124\/jpet.111.185686_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017386","article-title":"Adipose tissue deficiency and chronic inflammation in diabetic Goto-Kakizaki rats","volume":"6","author":"Xue","year":"2011","journal-title":"PLoS One"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524466664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524466664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.111.185686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T02:40:04Z","timestamp":1740019204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524466664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0022356524466664"],"URL":"https:\/\/doi.org\/10.1124\/jpet.111.185686","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling Diabetes Disease Progression and Salsalate Intervention in Goto-Kakizaki Rats","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.111.185686","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}